Cargando…

Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis

Statins can decrease hepatocellular carcinoma (HCC) occurrence, but the magnitude and the predictors of these effects remain unclear. This meta-analysis provides a pooled estimate of the impact of statin use on HCC occurrence. Pooled effects were calculated using a random-effects model by means of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Facciorusso, Antonio, Abd El Aziz, Mohamed A, Singh, Siddharth, Pusceddu, Sara, Milione, Massimo, Giacomelli, Luca, Sacco, Rodolfo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225931/ https://www.ncbi.nlm.nih.gov/pubmed/32260179 http://dx.doi.org/10.3390/cancers12040874

Ejemplares similares

Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Efficacy of Regorafenib in Hepatocellular Carcinoma Patients: A Systematic Review and Meta-Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2019)

Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review
por: Abd El Aziz, Mohamed A, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2020)

Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors
por: Pusceddu, Sara, et al.
Publicado: (2020)

Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review
por: Ramai, Daryl, et al.
Publicado: (2022)

Hospital Frailty Risk Score Is Independently Associated with Mortality and Encephalopathy in Hospitalized Patients with Hepatocellular Carcinoma
por: Ramai, Daryl, et al.
Publicado: (2021)

Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
por: Ramai, Daryl, et al.
Publicado: (2023)

Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Local ablative treatments for hepatocellular carcinoma: An updated review
por: Facciorusso, Antonio, et al.
Publicado: (2016)

Towards a tailored systemic therapy for liver cancer
por: Sacco, Rodolfo, et al.
Publicado: (2020)

Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report
por: Valente, Monica, et al.
Publicado: (2010)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
por: Ramai, Daryl, et al.
Publicado: (2021)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review
por: Khazaaleh, Shrouq, et al.
Publicado: (2022)

Transarterial radioembolization for hepatocellular carcinoma: a review
por: Sacco, Rodolfo, et al.
Publicado: (2016)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
por: Sacco, Rodolfo, et al.
Publicado: (2017)

Statins in Children, an Update
por: Fiorentino, Riccardo, et al.
Publicado: (2023)

Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
por: Cho, Yongin, et al.
Publicado: (2019)

Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis
por: Zhang, Xingfen, et al.
Publicado: (2023)

Update on entecavir in the management of severe forms of Hepatitis B
por: Sacco, Rodolfo
Publicado: (2012)

Succinate Dehydrogenase B Subunit Immunohistochemical Expression Predicts Aggressiveness in Well Differentiated Neuroendocrine Tumors of the Ileum
por: Milione, Massimo, et al.
Publicado: (2012)

Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia
por: Chen, Hsin-Hung, et al.
Publicado: (2016)

The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence
por: Pusceddu, Sara, et al.
Publicado: (2020)

Statins decrease leptin expression in human white adipocytes
por: Singh, Prachi, et al.
Publicado: (2018)

The stats are in: an update on statin use in COPD
por: Carlson, Alexa A, et al.
Publicado: (2015)

Statin Use in Prostate Cancer: An Update
por: Babcook, Melissa A., et al.
Publicado: (2016)

Statins Decrease Oxidative Stress and ICD Therapies
por: Bloom, Heather L., et al.
Publicado: (2010)

Statin and Ezetimibe Combination Therapy Decreases Mean Platelet Volume Compared to Statin Monotherapy
por: Lee, Jun-beom, et al.
Publicado: (2017)

Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm: A Clinical Challenge
por: Rossi, Roberta Elisa, et al.
Publicado: (2023)

Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
por: Chon, Young Eun, et al.
Publicado: (2023)

Update on Statin Treatment in Patients with Neuropsychiatric Disorders
por: Avan, Razieh, et al.
Publicado: (2021)

Incidence of Hepatocellular Carcinoma in Texas Latinos, 1995–2010: An Update
por: Ramirez, Amelie G., et al.
Publicado: (2014)

Statins decrease mortality in Lebanese patients with sepsis: A multicenter study
por: Ajrouche, Rola, et al.
Publicado: (2013)

Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
por: Scalorbi, Federica, et al.
Publicado: (2021)

Author Correction: Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
por: Scalorbi, Federica, et al.
Publicado: (2023)

Understanding the Drawbacks of the Current Tumor Staging Systems: How to Improve?
por: Giacomelli, Luca, et al.
Publicado: (2023)

TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma
por: Granito, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9pttllm9bv960dcqd8jo4kfd9c